Marion McCourt - Jun 7, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/**Marion McCourt
Stock symbol
REGN
Transactions as of
Jun 7, 2021
Transactions value $
-$168,720
Form type
4
Date filed
6/8/2021, 04:02 PM
Previous filing
May 10, 2021
Next filing
Jul 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $343 K +1 K +5.87% $342.93 18 K Jun 7, 2021 Direct F1
transaction REGN Common Stock Sale -$512 K -1 K -5.54% $511.65 17 K Jun 7, 2021 Direct F1
holding REGN Common Stock 108 Jun 7, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1 K -5.88% $0.00 16 K Jun 7, 2021 Common Stock 1 K $342.93 Direct F1, F2

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.